Season Three

13-19 of 19 results

  • Biotics for agricultural animals, with Prof. Steve Ricke PhD
    This episode, part of a series on the role of biotics in animal health, is a broad-ranging conversation on biotics for agricultural animals, with Prof. Steve Ricke PhD from University of Wisconsin-Madison. Prof. Ricke explains some of the different applications of biotics for poultry as well as swine and ruminants: rapid growth, efficient use of…

  • Episode 38: Microbes that break down mucus and milk to benefit the host, with Dr. Clara Belzer PhD
    Dr. Belzer, a molecular geneticist, specializes in studying the microorganisms that are equipped to break down the glycans in mucus and human milk within the host environment.

  • Episode 37: Targeting the gut microbiome in inflammatory bowel disease, with Prof. Harry Sokol MD PhD
    Prof. Harry Sokol MD PhD talks about the specific gut bacteria that seem to be important in IBD, as well as the challenge of targeting the gut microbiome for therapeutic effects.

  • Episode 36: Uncovering the mechanisms of sorbitol intolerance, with Dr. Jee-Yon Lee MD PhD
    Dr. Jee-Yon Lee MD PhD speaks about a recent paper on the mechanisms of sorbitol intolerance and the contributions of the gut microbiota.

  • Episode 35: Investigating gut microbiome links to chronic diseases, with Dr. Purna Kashyap MBBS
    Dr. Purna Kashyap MBBS talks about how to discover the complex factors that trigger and perpetuate chronic diseases such as inflammatory bowel disease.

  • Episode 34: New evidence on the virome in gut-brain communication and stress, with Nathaniel Ritz and Thomaz Bastiaanssen
    Nathaniel Ritz and Thomaz Bastiaanssen give an overview of the microbiota-gut-brain axis, then delve into a new study they led on the virome and its effects on stress responses in mice.

  • Episode 33: From probiotic mechanisms to applications, with Prof. Graciela Lorca PhD
    Prof. Graciela Lorca PhD talks about her experiences seeking out the mechanisms of action of a probiotic – including which molecules from bacteria may have beneficial effects – and bringing a probiotic through drug trials for use in Type 1 diabetes.